Previous close | 184.00 |
Open | 188.00 |
Bid | 188.00 x 10000 |
Ask | 191.00 x 10000 |
Day's range | 188.00 - 188.00 |
52-week range | 167.00 - 234.00 |
Volume | |
Avg. volume | 0 |
Market cap | 9.167B |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | 32.25 |
EPS (TTM) | 5.83 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.26 (0.69%) |
Ex-dividend date | 14 May 2024 |
1y target est | 462.55 |
The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug AdministrationWAYNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies and pioneer in intraosseous vascular access, today announced the launch of the Arrow™ EZ-IO™ Intraosseous Access Procedure Tray. This sterile, single-use tray includes all the components required for the IO access procedure, enabling a streamlined clinician workflow. The new Arrow™ EZ
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association Annual Meeting in San Antonio, TX, May 3 – 6, 2024, showcasing excellent patient experience* with the Prostatic Urethral Lift (PUL) with the UroLift™ System for benign prostatic hyperplasia (BPH). This year’s research marks the first time results from two randomized head-to-
Evaluate Teleflex's (TFX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.